INNOVATIVE
Resulting from 10Y+ of research, MitoStemX combines two small molecules that synergistically target
T cell metabolism, enhancing their fitness and persistence.
VERSATILE
Compatible with various CAR/TCR constructs, with multiple clinical-grade cell culture media, supports diverse culture vessels and a broad range of additives.
TRACEABLE
MitoStemX is chemically defined and animal component-free. It can be easily washed-out from culture media and quantified before infusion into patients.
"Enhancing Tscm is a top priority, as these cells are linked to improved clinical performance"
CSO, mid-sized biotech
About us
MPC Therapeutics is a spin-off from the University of Geneva, Switzerland. We combine world-class expertise in mitochondrial function (Prof. Jean-Claude Martinou, CSO) and T-cell metabolism (Dr. Mathias Wenes, CTO) to develop innovative products that enhance cell fitness, stemness and performance.
​
Our goal is to enable our partners to unlock the full potential of their cell therapies, by reliably producing efficient and durable cell therapy products.
Mathias Wenes
CTO
Mathias is an expert in immune cell metabolism. He has conducted his PhD with Prof. Mazzone at the VIB/University of Leuven, Belgium, and postdocs with Prof. Romero in Lausanne and Prof. Migliorini in Geneva. Mathias discovered the potential of MPC inhibition in immune cells and plays a key role in driving the project forward.
Jean-Claude Martinou
CSO
Jean-Claude is a globally recognized leader in cell metabolism and mitochondria research, having authored numerous key publications on the MPC. Notably, his lab at the University of Geneva discovered the MPC in 2012. Prof. Martinou recently retired from academia and now serves as the CSO of MPC Therapeutics.
Augustin de Bettignies
CBO
With a PhD and MBA, Augustin brings an experience from both major med tech companies and biotech startups. Augustin is responsible for building partnerships with pharmaceutical companies and overseeing legal and financial aspects, drawing from his extensive background in business development and consulting.
Raphael Martinou
CEO
Raphael holds an MSc from Imperial College London and has extensive experience in corporate innovation through his previous roles in the healthcare division of Air Liquide. As CEO, Raphaël leads the company’s strategic direction, fundraising efforts, and day-to-day management, ensuring the company remains on track toward its ambitious goals.
Be part of our journey!
CAREERS
Join us!
Explore our current openings and see where you fit in. With each new hire, we aim to bring in more passion and expertise to strengthen our mission
They support us, since 2020
Our award-winning team and technology have received invaluable support from a large number of organisations. We are grateful for their trust and contribution to our success.
